1. Gao, Xiaoli, Guo, Ziyi, Wang, Pengcheng, Liu, Zhiqiang, Wang, Zuomin. 2023. Transcriptomic analysis reveals the potential crosstalk genes and immune relationship between IgA nephropathy and periodontitis. In Frontiers in immunology, 14, 1062590. doi:10.3389/fimmu.2023.1062590. https://pubmed.ncbi.nlm.nih.gov/36793719/
2. Himes, Blanca E, Jiang, Xiaofeng, Wagner, Peter, Weiss, Scott T, Lu, Quan. 2014. RNA-Seq transcriptome profiling identifies CRISPLD2 as a glucocorticoid responsive gene that modulates cytokine function in airway smooth muscle cells. In PloS one, 9, e99625. doi:10.1371/journal.pone.0099625. https://pubmed.ncbi.nlm.nih.gov/24926665/
3. Li, Jinjiao, Zhang, Panshi, Xia, Yun. 2021. Study on CCDC69 interfering with the prognosis of patients with breast cancer through PPAR signal pathway. In European journal of histochemistry : EJH, 65, . doi:10.4081/ejh.2021.3207. https://pubmed.ncbi.nlm.nih.gov/33634680/
4. Yi, Yi, Xu, Tao, Tan, Yufang, Wu, Yiping, Zhang, Qi. 2022. CCDC69 is a prognostic marker of breast cancer and correlates with tumor immune cell infiltration. In Frontiers in surgery, 9, 879921. doi:10.3389/fsurg.2022.879921. https://pubmed.ncbi.nlm.nih.gov/35910470/
5. Wang, Zhen, Ren, Huiyang, Zhu, Guolian, Cao, Hongyi, Chen, Bo. 2023. High expression of CCDC69 is correlated with immunotherapy response and protective effects on breast cancer. In BMC cancer, 23, 974. doi:10.1186/s12885-023-11411-2. https://pubmed.ncbi.nlm.nih.gov/37828454/
6. Cui, Long, Zhou, Fang, Chen, Cui, Wang, Chi Chiu. 2019. Overexpression of CCDC69 activates p14ARF/MDM2/p53 pathway and confers cisplatin sensitivity. In Journal of ovarian research, 12, 4. doi:10.1186/s13048-019-0479-3. https://pubmed.ncbi.nlm.nih.gov/30651135/
智鼠故事 
